The survival rate for pediatric acute and fulminant myocarditis has not improved over the past 10 years in Japan.
Answers are grounded in this paper and cite their sources.
No improvement in pediatric myocarditis survival over 10 years; leaves open optimal strategies and need for prospective trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Matsuura et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: